GlassScriptPhysician profile
Alyssa Cappolla Parrish
NPI 1710467709
$412.08
in general payments reported to CMS, 2019-2025
9 companies · $52.14 in 2025
The $52.14 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.08 · 2022: $44.06 · 2023: $200 · 2024: $84.22 · 2025: $52.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $124.98 | 2023 | |
| Qol Medical, LLC | $89.96 | 2024-2025 | Sucraid, Sucraid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.03 | 2022-2023 | Trulance |
| Davol INC. | $32.08 | 2021 | |
| Janssen Biotech, INC. | $30.89 | 2024 | Stelara, Simponi, Tremfya |
| Ardelyx, INC. | $17.68 | 2023 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $15.51 | 2024 | |
| Vivus LLC | $15.00 | 2022 | |
| Ironwood Pharmaceuticals, INC | $14.95 | 2023 | Linzess |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Cappolla Parrish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.